PROTECH C3 + 2I

Šalis: Australija

kalba: anglų

Šaltinis: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Veiklioji medžiaga:

LEPTOSPIROSIS - DOG - LEPTOSPIRA ICTEROHAEMORRHAGIAE; CANINE ADENO VIRUS TYPE 2; CANINE CORONAVIRUS VACCINE - ANTIGEN; CANINE DISTEMPER VIRUS STRAIN ONDERSTEPOORT; CANINE PARVO VIRUS

Prieinama:

Boehringer Ingelheim Animal Health Australia Pty. Ltd.

INN (Tarptautinis Pavadinimas):

canine distemper virus+canine adenovirus+canine parvovirus + others

Vaisto forma:

MISC. VACCINES OR ANTI SERA

Sudėtis:

LEPTOSPIROSIS - DOG - LEPTOSPIRA ICTEROHAEMORRHAGIAE VACCINE Active 0.0 U; CANINE ADENO VIRUS TYPE 2 VACCINE-VIRAL Active 0.0 U; CANINE CORONAVIRUS VACCINE - ANTIGEN VACCINE-VIRAL Active 0.0 U; CANINE DISTEMPER VIRUS STRAIN ONDERSTEPOORT VACCINE-VIRAL Active 0.0 U; CANINE PARVO VIRUS VACCINE-VIRAL Active 0.0 U

Vienetai pakuotėje:

25 x 1 dose Protech C3 and 25 x 1 dose C2i

Klasė:

VM - Veterinary Medicine

Farmakoterapinė grupė:

DOG - OVER 6 WEEKS OLD

Gydymo sritis:

IMMUNOTHERAPY

Terapinės indikacijos:

CANINE ADENOVIRUS - TYPE 1 | CANINE ADENOVIRUS - TYPE 2 | CANINE CORONAVIRUS | CANINE DISTEMPER | CANINE PARVOVIRUS | LEPTOSPIRA ICTEROHAEMORRHAGIAE | PARVOVIRUS

Produkto santrauka:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG - OVER 6 WEEKS OLD: [CANINE ADENOVIRUS - TYPE 1, CANINE ADENOVIRUS - TYPE 2, CANINE CORONAVIRUS, CANINE DISTEMPER, CANINE PARVOVIRUS, LEPTOSPIRA ICTEROHAEMORRHAGIAE]; Live vaccine for the immunisation of healthy dogs, 6 weeks of age or older to protect against disease caused by canine distemper virus, canine adenovirus types 1&2, canine parvovirus and L.interrogans serovar copenhageni and aid in viral shedding (CPV infSee DIRECTIONS FOR USE, PRECAUTIONS and SIDE EFFECTS on label.

Autorizacija statusas:

Registered

Leidimo data:

2023-07-01

Pakuotės lapelis

BOEHRINGER INGELHEIM PTY LIMITED, VETMEDICA DIVISION
PROTECH C3 + 2I
51490/101278
COMPANY NAME:
PRODUCT NAME:
APVMA APPROVAL NO:
LABEL NAME:
PROTECH C3 + 2I
SIGNAL HEADINGS:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
CONSTITUENT
STATEMENTS:
Attenuated canine distemper virus (10^2.9 TCID50)
Attenuated canine adenovirus type 2 (10^3.62TCID50)
Attenuated canine parvovirus (CPV-2b strain 10^5.5 TCID50)
Inactivated canine coronavirus (RP
≥
1.62)
Inactivated Bacterins of Leptospira interrogans serovar Copenhageni
(RP# 1.0)
CLAIMS:
Live vaccine for the immunisation of healthy dogs, 6 weeks of age or
older to protect
against disease caused by canine distemper virus, canine adenovirus
type 1, canine
adenovirus type 2, canine parvovirus and Leptospira interrogans
serovar Copenhageni
and aid in protection against disease caused by canine coronavirus.
This vaccine prevents
viral shedding caused by canine parvovirus infection. Early protection
of puppies with final
vaccination at 10 weeks.
NET CONTENTS:
25 x 1 dose Protech C3
25 x 1 dose Protech C2i
DIRECTIONS FOR USE:
A new sterile syringe and needle should always be used to administer
this vaccine.
Reconstitute the freeze-dried Protech® C3 vaccine with sterile water
for injection (1 mL) or
Protech® C2i vaccine.
Inject subcutaneously within 20 minutes of reconstitution.
Do not use chemicals or disinfectants to sterilise the skin, needles
or syringes.
RESTRAINTS:
CONTRAINDICATIONS:
PRECAUTIONS:
Vaccinate only healthy dogs with normal temperatures.
Dogs under treatment with immunosuppressive drugs should not be
vaccinated. RLP APPROVED
The use of these vaccines in pregnant bitches is not recommended.
SIDE EFFECTS:
Some animals may show transient post-vaccination pain, malaise and
depression.
Allergic reactions such as anaphylaxis occur rarely and may require
parenteral treatment
with an antihistamine, a corticosteroid or adrenalin as appropriate.
Local site reactions after vaccination are rare but transient
swelling, pain and subcuta

Prekės savybės

CS: 1.7.2
Page:
1
MATERIAL SAFETY DATA SHEET
4
of
Infosafe No™
LQ08G
August 2011
ISSUED by BOEHRING
Issue Date :
PROTECH® C3 +2I
Product Name :
Not classified as hazardous
1. IDENTIFICATION OF THE MATERIAL AND SUPPLIER
PROTECH® C3 +2I
PRODUCT NAME
Boehringer Ingelheim Pty. Limited
COMPANY NAME
78 Waterloo Rd North Ryde
NSW 2113 Australia
ADDRESS
1800 038 037
EMERGENCY TEL.
Tel: [phone]
Fax: [phone]
TELEPHONE/FAX
NUMBER
[e-mail]
EMAIL
For the immunisation of healthy dogs against diseases caused by Canine
Distemper, Canine Adenovirus types 1 and 2, Canine Parvovirus, Canine
Coronavirus and Leptospira interrogans serovar Copenhageni.
RECOMMENDED USE
2. HAZARDS IDENTIFICATION
Not classified as hazardous
NON-HAZARDOUS SUBSTANCE.
NON-DANGEROUS GOODS.
Hazard classification according to the criteria of NOHSC.
Dangerous goods classification according to the Australia Dangerous
Goods
Code.
HAZARD
CLASSIFICATION
3. COMPOSITION/INFORMATION ON INGREDIENTS
Product contains Canine distemper virus, Canine adenovirus, Canine
parvovirus,
Canine coronavirus and Leptospira interrogans serovar Copenhageni.
INFORMATION ON
COMPOSITION
NAME
CAS
PROPORTION
INGREDIENTS
Ingredients determined
not to be hazardous
-
Balance
Live virus vaccine
-
4. FIRST AID MEASURES
No special precautions required. However, if inhaled, remove affected
person
from contaminated area. Keep at rest until recovered. If symptoms
persist seek
medical attention.
INHALATION
Do not induce vomiting. Wash out mouth thoroughly with water. If
symptoms
develop seek medical attention.
INGESTION
Wash affected area thoroughly with soap and water. If symptoms develop
seek
medical attention.
Self-Injection: Accidental self injection may lead to an inflammatory
response
and medical advice should be sought on the management of deep
injections,
particularly those near a joint or associated with bruising. If
possible the
application of gentle squeezing pressure with absorbent material (e.g.
facial
tissues) at the injection site will

Saugos duomenų lapas

REVISION. . . . . .
OPERATOR . . . . .
DATE . . . . . . . . .
ART #. . . . . . . . .
ITEM # . . . . . . .
PRODUCT . . . . . .
TYPE/SIZE . . . . . .
TEMPLATE #. . . . .
DIMENSIONS . . . .
CORNER RADIUS. . .
PDF . . . . . . . . . . .
REV LEVEL. . . . . . .
BOEHRINGER
INGELHEIM
7
lsh
21May12
176401-00
REQUESTED
Protech C3+2i
Tray / 25 x 1 mL
306
3” x 8-1/2”
.312”
21May12 lsh
00
BLACK
PMS 107
PMS 499
TOP
(B)
Exp.:
PROTECH® C3+2I
DIMENSIONS: 76.2 MM X 215.9 MM
THIS FILE IS 100% WHEN PRINTED ON A4 (OR A3, AS APPLICABLE)
FONT SIZES:
MAIN PANEL: 6.5 pt
TRADENAME: 13 pt
SIDE PANELS: 6.5 pt
LEFT FLAP:
TRADENAME: 13 pt
TEXT: 5.5 pt
RIGHT FLAP:
TRADENAME: 13 pt
TEXT: 5.5 pt
176401-00
PMS 582
abcd
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
PROTECH® C3+2I
ACTIVE CONSTITUENTS: attenuated canine
distemper virus (10
2.9
TCID
50
), canine
adenovirus type 2 (10
3.62
TCID
50
) and canine
parvovirus (CPV-2b strain, 10
5.5
TCID
50
),
inactivated canine coronavirus (RP≥ 1.62) and
bacterins of
Leptospira interrogans
serovar
Copenhageni (RP≥ 1.0).
CONTENTS:
25 single dose vials of PROTECH C3
25 single dose vials of PROTECH C2I
PROTECH® C3+2I
Live vaccine for the immunisation of healthy dogs, 6 weeks of
age or older to protect against disease caused by canine
distemper virus, canine adenovirus type 1, canine adenovirus
type 2, canine parvovirus and
Leptospira interrogans
serovar
Copenhageni and aid in protection against disease caused by
canine coronavirus.
Early protection of puppies with final vaccination at 10 weeks.
READ ENCLOSED LEAFLET BEFORE USING THIS PRODUCT
DOSE: Contents of one vial of PROTECH C3 to be reconstituted with
one vial of PROTECH C2I injected subcutaneously.
Store between 2-8°C. Do not freeze. Protect from light.
Please note leaflet, label and tray only are recyclable.
Protech® C3+2i is a registered trademark of Boehringer Ingelheim
Vetmedica, Inc.
BOEHRINGER INGELHEIM PTY LIMITED
ANIMAL HEALTH DIVISION
78 WATERLOO ROAD
NORTH RYDE NSW 2113
APVMA Approval No. 5149